Pyrosequencing reveals the complex polymicrobial nature of invasive pyogenic infections: Microbial constituents of empyema, liver abscess, and intracerebral abscess

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 10, 2012, Pages 2679-2691

  Sibley, C D ^a   Church, D L ^a   Surette, M G ^a,c   Dowd, S E ^d   Parkins, M D ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Molecular Research LP MR DNA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BRAIN ABSCESS; CLINICAL ARTICLE; CONTROLLED STUDY; EMPYEMA; GENUS; HUMAN; INTERMETHOD COMPARISON; INTRACEREBRAL ABSCESS; MICROBIAL COMMUNITY; MICROBIAL IDENTIFICATION; NONHUMAN; PLEURA FLUID; PRIORITY JOURNAL; PYOGENIC LIVER ABSCESS; PYROSEQUENCING;

ADOLESCENT; ADULT; AGED; BACTERIAL LOAD; BACTERIAL TYPING TECHNIQUES; BRAIN ABSCESS; CHILD; CHILD, PRESCHOOL; CULTURE TECHNIQUES; DNA, BACTERIAL; EMPYEMA; GRAM-NEGATIVE BACTERIA; HUMANS; LIVER ABSCESS, PYOGENIC; MIDDLE AGED; PLEURAL EFFUSION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; YOUNG ADULT;

EID: 84869132419     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1614-x     Document Type: Article

References (71)

1. Laupland KB, Ross T, Church DL et al (2006) Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 12:224-230
2. Xiao F, Tseng MY, Teng LJ et al (2005) Brain abscess: clinical experience and analysis of prognostic factors. Surg Neurol 63:442-449, discussion 449-50
3. Roche M, Humphreys H, Smyth E et al (2003) A twelve-Year review of central nervous system bacterial abscesses; presentation and aetiology. Clin Microbiol Infect 9:803-809
4. Chen SC, Tsai SJ, Chen CH et al (2008) Predictors of mortality in patients with pyogenic liver abscess. Neth J Med 66:196-203
5. Kaplan GG, Gregson DB, Laupland KB (2004) Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol 2:1032-1038
6. Alvarez Pérez JA, González JJ, Baldonedo RF et al (2001) Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg 181:177-186
7. Rahman NM, Chapman SJ, Davies RJ (2006) The approach to the patient with a parapneumonic effusion. Clin Chest Med 27:253-266
8. Wolcott RD, Gontcharova V, Sun Yet al (2009) Bacterial diversity in surgical site infections: not just aerobic cocci any more. J Wound Care 18:317-323
9. Dowd SE, Sun Y, Secor PR et al (2008) Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8:43
10. Dowd SE, Wolcott RD, Sun Yet al (2008) Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 3:e3326
11. Al Masalma M, Armougom F, Scheld WM et al (2009) The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clin Infect Dis 48:1169-1178
12. Al Masalma M, Lonjon M, Richet H et al (2012) Metagenomic analysis of brain abscesses identifies specific bacterial associations. Clin Infect Dis 54:202-210
13. Sibley CD, Rabin H, Surette MG (2006) Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol 1:53-61
14. Sibley CD, Parkins MD, Rabin HR et al (2008) A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 105:15070-15075
15. Sibley CD, Grinwis ME, Field TR et al (2010) McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients. J Med Microbiol 59:534-540
16. Sibley CD, Grinwis ME, Field TR et al (2011) Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One 6:e22702
17. Clinical and Laboratory Standards Institute (CLSI) (2007)Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved Standard-Seventh edition. CLSI, Wayne, PA
18. Clinical and Laboratory Standards Institute (CLSI) (2008) Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; Approved Guideline. CLSI, Wayne, PA
19. Clinical and Laboratory Standards Institute (CLSI) (2011)Performance standards for antimicrobial susceptibility testing; Twentyfirst informational supplement. CLSI, Wayne, PA
20. Dowd SE, Sun Y, Wolcott RD et al (2008) Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonellainfected pigs. Foodborne Pathog Dis 5:459-472
21. Dowd SE, Callaway TR,Wolcott RD et al (2008) Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol 8:125
22. Gontcharova V, Youn E, Wolcott RD et al (2010) Black box chimera check (B2C2): a Windows-based software for batch depletion of chimeras from bacterial 16S rRNA gene datasets. Open Microbiol J 4:47-52
23. Dowd SE, Zaragoza J, Rodriguez JR et al (2005) Windows. NET Network Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST). BMC Bioinformatics 6:93
24. Cole JR, Wang Q, Cardenas E et al (2009) The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37:D141-D145
25. Mandell GL (2009) Mandell, Douglas, and Bennett's principles and practices of infectious diseases, 7th edn. Elsevier, Philadelphia
26. Light RW (1995) A new classification of parapneumonic effusions and empyema. Chest 108:299-301
27. Laupland KB, Gregson DB, Zygun DA et al (2004) Severe bloodstream infections: a population-based assessment. Crit Care Med 32:992-997
28. Fajardo A, Martínez-Martín N, Mercadillo M et al (2008) The neglected intrinsic resistome of bacterial pathogens. PLoS One 3: e1619
29. European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST Expert rules in antimicrobial susceptibility testing, version 1, April 2008. Available online at: http://www.srga.org/eucastwt/ EUCAST%20Expert%20rules%20final% 20April-20080407.pdf. Accessed 15 Nov 2011
30. Laupland KB, Parkins MD, Ross T et al (2007) Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region. Clin Microbiol Infect 13:683-688
31. DiBaise JK, Zhang H, Crowell MD et al (2008) Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83:460-469
32. Hattori M (2010) Genetic analysis of intestinal microbiome by metagenomics. Nihon Rinsho 68(Suppl 8):506-510
33. Wolcott RD, Gontcharova V, Sun Y et al (2009) Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 9:226
34. Gontcharova V, Youn E, Sun Y et al (2010) A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J 4:8-19
35. Smith DM, Snow DE, Rees E et al (2010) Evaluation of the bacterial diversity of pressure ulcers using bTEFAP pyrosequencing. BMC Med Genomics 3:41
36. Erb-Downward JR, Thompson DL, Han MK et al (2011) Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 6:e16384
37. Duan K, Dammel C, Stein J et al (2003) Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50:1477-1491
38. Sibley CD, Duan K, Fischer C et al (2008) Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 4:e1000184
39. Shinzato T, Saito A (1994) A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe. J Med Microbiol 40:118-123
40. Wade BH, Kasper DL, Mandell GL (1983) Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-Treated bacteria. J Antimicrob Chemother 12(Suppl C):51-62
41. Rotstein OD, Pruett TL, Simmons RL (1985) Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis 7:151-170
42. Edwards R (1997) Resistance to beta-lactam antibiotics in Bacteroides spp. J Med Microbiol 46:979-986
43. Brook I (2004) Beta-lactamase-producing bacteria in mixed infections. Clin Microbiol Infect 10:777-784
44. Brook I (2002) Microbiology of polymicrobial abscesses and implications for therapy. J Antimicrob Chemother 50:805-810
45. Prasad KN, Mishra AM, Gupta D et al (2006) Analysis of microbial etiology and mortality in patients with brain abscess. J Infect 53:221-227
46. Jansson AK, Enblad P, Sjölin J (2004) Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. Eur J Clin Microbiol Infect Dis 23:7-14
47. Carpenter J, Stapleton S, Holliman R (2007) Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis 26:1-11
48. Moore-Gillon JC, Eykyn SJ, Phillips I (1981) Microbiology of pyogenic liver abscess. Br Med J (Clin Res Ed) 283:819-821
49. Corredoira J, Casariego E, Moreno C et al (1998) Prospective study of Streptococcus milleri hepatic abscess. Eur J Clin Microbiol Infect Dis 17:556-560
50. Maskell NA, Davies CW, Nunn AJ et al (2005) U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352:865-874
51. Ahmed RA, Marrie TJ, Huang JQ (2006) Thoracic empyema in patients with community-Acquired pneumonia. Am J Med 119:877-883
52. Rahimian J, Wilson T, Oram V et al (2004) Pyogenic liver abscess: recent trends in etiology andmortality. Clin Infect Dis 39:1654-1659
53. Chan KS, Chen CM, Cheng KC et al (2005) Pyogenic liver abscess: a retrospective analysis of 107 patients during a 3-Year period. Jpn J Infect Dis 58:366-368
54. Sabbaj J (1984) Anaerobes in liver abscess. Rev Infect Dis 6(Suppl 1):S152-S156
55. Zaura E, Keijser BJ, Huse SMet al (2009) Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 9:259
56. Charlson ES, Bittinger K, Haas AR et al (2011) Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184:957-963
57. Charlson ES, Chen J, Custers-Allen R et al (2010) Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One 5:e15216
58. Ruiz-Hernández JJ, León-Mazorra M, Conde-Martel A et al (2007) Pyogenic liver abscesses: mortality-related factors. Eur J Gastroenterol Hepatol 19:853-858
59. Zibari GB, Maguire S, Aultman DF et al (2000) Pyogenic liver abscess. Surg Infect (Larchmt) 1:15-21
60. Lipsky BA (2007) Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 13:351-353
61. Lipsky BA, Armstrong DG, Citron DM et al (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, doubleblinded, multicentre trial. Lancet 366:1695-1703
62. Solomkin J, Teppler H, Graham DR et al (2004) Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-Tazobactam. J Antimicrob Chemother 53(Suppl 2):ii51-ii57
63. Wacha H, Hau T, Dittmer R et al (1999) Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 384:24-32
64. Dupont H, Friggeri A, Touzeau J et al (2011) Enterococci increase the morbidity and mortality associated with severe intra-Abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother 66:2379-2385
65. Nocker A, Richter-Heitmann T, Montijn R et al (2010) Discrimination between live and dead cellsin bacterial communities from environmental water samples analyzed by 454 pyrosequencing. Int Microbiol 13:59-65
66. Castillo M, Martín-Orúe SM, Manzanilla EG et al (2006) Quantification of total bacteria, enterobacteria and lactobacilli populations in pig digesta by real-Time PCR. Vet Microbiol 114:165-170
67. Grahn N, Olofsson M, Ellnebo-Svedlund K et al (2003) Identification of mixed bacterial DNA contamination in broad-range PCR amplification of 16S rDNA V1 and V3 variable regions by pyrosequencing of cloned amplicons. FEMS Microbiol Lett 219:87-91
68. Spangler R, Goddard NL, Thaler DS (2009) Optimizing Taq polymerase concentration for improved signal-To-noise in the broad range detection of low abundance bacteria. PLoS One 4:e7010
69. McGowan JE Jr (2006) Resistance in nonfermenting gramnegative bacteria: multidrug resistance to the maximum. Am J Infect Control 34:S29-S37, discussion S64-73
70. Boucher HW, Talbot GH, Bradley JS et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12
71. Rice LB (2006) Antimicrobial resistance in gram-positive bacteria. Am J Infect Control 34:S11-S19, discussion S64-73